Jaguar Health (JAGX) Cash from Investing Activities (2015 - 2025)
Jaguar Health (JAGX) reported Cash from Investing Activities of $13000.0 for Q4 2025, up 106.05% year-over-year from $6309.3 in Q4 2024, and up 106.05% quarter-over-quarter from -$215000.0 in Q4 2024.
Jaguar Health (JAGX) Cash from Investing Activities (2015 - 2025) Analysis & Trends
Jaguar Health (JAGX) has 9 years of Cash from Investing Activities data on file, last reported at $13000.0 in Q4 2025.
- Cash from Investing Activities for Q4 2025 came in at $13000.0, up 106.05% year-over-year; the trailing twelve-month figure through Dec 2025 was -$202000.0 (up 6.05% YoY), and the FY2025 annual result was -$41000.0, up 82.25% from the prior year.
- Cash from Investing Activities improved to $13000.0 in Q4 2025 per JAGX's latest filing, from -$215000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $10.5 million in Q4 2021 and troughed at -$10.5 million in Q3 2021.
- A 4-year average of -$103166.7 and a median of -$135500.0 in 2022 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities sank 103.45% in 2022, then jumped 106.05% in 2025.
- A 4-year view of Cash from Investing Activities shows it stood at $10.5 million in 2021, then slumped by 103.45% to -$361000.0 in 2022, then surged by 40.44% to -$215000.0 in 2024, then jumped by 106.05% to $13000.0 in 2025.
- Business Quant data shows JAGX's Cash from Investing Activities at $13000.0 in Q4 2025, -$215000.0 in Q4 2024, and -$361000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 579,519.10 |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Dec 31, 2024 | -215,000.00 |
| Dec 31, 2024 | -215,000.00 |
| Dec 31, 2022 | -361,000.00 |
| Dec 31, 2022 | -361,000.00 |
| Sep 30, 2022 | -56,000.00 |
| Sep 30, 2022 | -56,000.00 |
| Dec 31, 2021 | 10.48 Mn |
| Dec 31, 2021 | 10.48 Mn |
| Sep 30, 2021 | -10.48 Mn |
| Sep 30, 2021 | -10.48 Mn |
| Mar 31, 2020 | -7,000.00 |
| Mar 31, 2020 | -7,000.00 |
| Mar 31, 2018 | -6,527.00 |
| Mar 31, 2018 | -6,527.00 |
| Dec 31, 2017 | -11,293.00 |
| Dec 31, 2017 | -11,293.00 |
| Sep 30, 2017 | -2.06 Mn |
| Sep 30, 2017 | -2.06 Mn |